Edwards Lifesciences Corp
Market Cap
50B
Short interest (May 15)
2.0%
Net Short (Jun 03 ): -0.1%
Borrow Fee
0.41%
↓ 0.3%
Available Shares
8M
↓ 19.8%
Price Chart
Company Overview
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.